Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Dr. Josh Sabari, an assistant professor within the Division of Medication at NYU Grossman College of Medication and CURE’s editor-in-chief, sat down with...
Tamron Little was recognized with peritoneal mesothelioma in 2007 as a 21-year-old new mom. Atone for Tamron's blogs right here!After I take into consideration...
